Trajectories of serum α-fetoprotein and intermediate-stage hepatocellular carcinoma outcomes after transarterial chemoembolization: A longitudinal, retrospective, multicentre, cohort study

BACKGROUND: α-fetoprotein (AFP) response has been proven a key tumor marker for hepatocellular carcinoma (HCC), but its definition remains controversial. This study aims to characterize AFP trajectories after transarterial chemoembolization (TACE) and examine its impact on clinical outcomes. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Linbin, Shen, Lujun, Wu, Zhixian, Shi, Yanhong, Hou, Peifeng, Xue, Zengfu, Lin, Cheng, Chen, Xiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035711/
https://www.ncbi.nlm.nih.gov/pubmed/35480077
http://dx.doi.org/10.1016/j.eclinm.2022.101391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035711/
https://www.ncbi.nlm.nih.gov/pubmed/35480077
http://dx.doi.org/10.1016/j.eclinm.2022.101391

Ejemplares similares